1207-P: Gestational Diabetes Mellitus (GDM)—Outcomes for Normal-Weight Individuals
Excess body weight is associated with GDM, and BMI ≥ 25kg/m2 is often used as a criterion in risk factor-based screening programs. However, individuals with a normal BMI account for a significant proportion of those diagnosed with GDM (20-60% depending on the population studied), and comparative cli...
Gespeichert in:
| Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | Supplement_1 |
| container_start_page | 1 |
| container_title | Diabetes (New York, N.Y.) |
| container_volume | 72 |
| creator | MOAZZAMI, MITRA VENKATESAN, NANDITHA SANKARAN RAJAGOPALAN, KAMALNATH VELLA, ADRIAN EGAN, AOIFE M. |
| description | Excess body weight is associated with GDM, and BMI ≥ 25kg/m2 is often used as a criterion in risk factor-based screening programs. However, individuals with a normal BMI account for a significant proportion of those diagnosed with GDM (20-60% depending on the population studied), and comparative clinical outcome data are limited. Our aim was to assess pregnancy outcomes for people with GDM and a baseline BMI < 25kg/m2, compared to a reference group with GDM and a BMI of 25-30kg/m2. Included subjects attended our institution for prenatal care from 2018-22 and GDM was diagnosed using universal screening and Carpenter and Coustan criteria. We identified 524 individuals with a BMI < 25kg/m2 and 705 with a BMI 25-30kg/m2. Those with a BMI |
| doi_str_mv | 10.2337/db23-1207-P |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2849359685</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2849359685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c645-bbbd5283f58042ca7a6146ab693e6b30ce713203352892a08fc8e5b03880bb823</originalsourceid><addsrcrecordid>eNotkMFKAzEQhoMoWKsnX2DBiyLRJLO7yXqTVmuhtT0U9BaS3aymbJua7ArefAif0CcxZWUO_2E-fmY-hM4puWEA_LbSDDBlhOPlARrQAgoMjL8eogEhlGHKC36MTkJYE0LyOAO06um7ZGJCq1rrtqpJxlZp05qQzE3T2LYLyeVkPL_6_f5ZdG3pNnFTO588O79RDX4x9u29Tabbyn7aqlNNOEVHdQxz9p9DtHp8WI2e8GwxmY7uZ7jM0wxrrauMCagzQVJWKq5ymuZK5wWYXAMpDafACECECqaIqEthMk1ACKK1YDBEF33tzruPLt4v167z8YEgmUgLyIpcZJG67qnSuxC8qeXO243yX5ISubcm99bk3oNcwh-9Fl4l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2849359685</pqid></control><display><type>article</type><title>1207-P: Gestational Diabetes Mellitus (GDM)—Outcomes for Normal-Weight Individuals</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>MOAZZAMI, MITRA ; VENKATESAN, NANDITHA ; SANKARAN RAJAGOPALAN, KAMALNATH ; VELLA, ADRIAN ; EGAN, AOIFE M.</creator><creatorcontrib>MOAZZAMI, MITRA ; VENKATESAN, NANDITHA ; SANKARAN RAJAGOPALAN, KAMALNATH ; VELLA, ADRIAN ; EGAN, AOIFE M.</creatorcontrib><description><![CDATA[Excess body weight is associated with GDM, and BMI ≥ 25kg/m2 is often used as a criterion in risk factor-based screening programs. However, individuals with a normal BMI account for a significant proportion of those diagnosed with GDM (20-60% depending on the population studied), and comparative clinical outcome data are limited. Our aim was to assess pregnancy outcomes for people with GDM and a baseline BMI < 25kg/m2, compared to a reference group with GDM and a BMI of 25-30kg/m2. Included subjects attended our institution for prenatal care from 2018-22 and GDM was diagnosed using universal screening and Carpenter and Coustan criteria. We identified 524 individuals with a BMI < 25kg/m2 and 705 with a BMI 25-30kg/m2. Those with a BMI <25 kg/m2 were younger (22 v 28 years, p<0.001), and a higher proportion identified as Asian (15.5% v 9.22%; p=0.04). Table 1 contains pregnancy outcomes. Those with a BMI <25kg/m2 were less likely to receive pharmacological GDM therapy, but their infants had a higher rate of neonatal ICU admission. Postpartum, those with a BMI <25kg/m2 were less likely to have an oral glucose tolerance test but were at similar risk of glucose intolerance. These findings suggest that normal weight women with GDM may experience higher risk of adverse outcomes compared to their overweight counterparts. These data support universal screening and will be used to inform patients on their risk profile and improve postpartum screening.]]></description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db23-1207-P</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Body weight ; Diabetes mellitus ; Gestational diabetes ; Glucose tolerance ; Intolerance ; Neonates ; Overweight ; Population studies ; Postpartum ; Pregnancy complications ; Risk factors</subject><ispartof>Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1</ispartof><rights>Copyright American Diabetes Association Jun 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>MOAZZAMI, MITRA</creatorcontrib><creatorcontrib>VENKATESAN, NANDITHA</creatorcontrib><creatorcontrib>SANKARAN RAJAGOPALAN, KAMALNATH</creatorcontrib><creatorcontrib>VELLA, ADRIAN</creatorcontrib><creatorcontrib>EGAN, AOIFE M.</creatorcontrib><title>1207-P: Gestational Diabetes Mellitus (GDM)—Outcomes for Normal-Weight Individuals</title><title>Diabetes (New York, N.Y.)</title><description><![CDATA[Excess body weight is associated with GDM, and BMI ≥ 25kg/m2 is often used as a criterion in risk factor-based screening programs. However, individuals with a normal BMI account for a significant proportion of those diagnosed with GDM (20-60% depending on the population studied), and comparative clinical outcome data are limited. Our aim was to assess pregnancy outcomes for people with GDM and a baseline BMI < 25kg/m2, compared to a reference group with GDM and a BMI of 25-30kg/m2. Included subjects attended our institution for prenatal care from 2018-22 and GDM was diagnosed using universal screening and Carpenter and Coustan criteria. We identified 524 individuals with a BMI < 25kg/m2 and 705 with a BMI 25-30kg/m2. Those with a BMI <25 kg/m2 were younger (22 v 28 years, p<0.001), and a higher proportion identified as Asian (15.5% v 9.22%; p=0.04). Table 1 contains pregnancy outcomes. Those with a BMI <25kg/m2 were less likely to receive pharmacological GDM therapy, but their infants had a higher rate of neonatal ICU admission. Postpartum, those with a BMI <25kg/m2 were less likely to have an oral glucose tolerance test but were at similar risk of glucose intolerance. These findings suggest that normal weight women with GDM may experience higher risk of adverse outcomes compared to their overweight counterparts. These data support universal screening and will be used to inform patients on their risk profile and improve postpartum screening.]]></description><subject>Body weight</subject><subject>Diabetes mellitus</subject><subject>Gestational diabetes</subject><subject>Glucose tolerance</subject><subject>Intolerance</subject><subject>Neonates</subject><subject>Overweight</subject><subject>Population studies</subject><subject>Postpartum</subject><subject>Pregnancy complications</subject><subject>Risk factors</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNotkMFKAzEQhoMoWKsnX2DBiyLRJLO7yXqTVmuhtT0U9BaS3aymbJua7ArefAif0CcxZWUO_2E-fmY-hM4puWEA_LbSDDBlhOPlARrQAgoMjL8eogEhlGHKC36MTkJYE0LyOAO06um7ZGJCq1rrtqpJxlZp05qQzE3T2LYLyeVkPL_6_f5ZdG3pNnFTO588O79RDX4x9u29Tabbyn7aqlNNOEVHdQxz9p9DtHp8WI2e8GwxmY7uZ7jM0wxrrauMCagzQVJWKq5ymuZK5wWYXAMpDafACECECqaIqEthMk1ACKK1YDBEF33tzruPLt4v167z8YEgmUgLyIpcZJG67qnSuxC8qeXO243yX5ISubcm99bk3oNcwh-9Fl4l</recordid><startdate>20230620</startdate><enddate>20230620</enddate><creator>MOAZZAMI, MITRA</creator><creator>VENKATESAN, NANDITHA</creator><creator>SANKARAN RAJAGOPALAN, KAMALNATH</creator><creator>VELLA, ADRIAN</creator><creator>EGAN, AOIFE M.</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20230620</creationdate><title>1207-P: Gestational Diabetes Mellitus (GDM)—Outcomes for Normal-Weight Individuals</title><author>MOAZZAMI, MITRA ; VENKATESAN, NANDITHA ; SANKARAN RAJAGOPALAN, KAMALNATH ; VELLA, ADRIAN ; EGAN, AOIFE M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c645-bbbd5283f58042ca7a6146ab693e6b30ce713203352892a08fc8e5b03880bb823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Body weight</topic><topic>Diabetes mellitus</topic><topic>Gestational diabetes</topic><topic>Glucose tolerance</topic><topic>Intolerance</topic><topic>Neonates</topic><topic>Overweight</topic><topic>Population studies</topic><topic>Postpartum</topic><topic>Pregnancy complications</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MOAZZAMI, MITRA</creatorcontrib><creatorcontrib>VENKATESAN, NANDITHA</creatorcontrib><creatorcontrib>SANKARAN RAJAGOPALAN, KAMALNATH</creatorcontrib><creatorcontrib>VELLA, ADRIAN</creatorcontrib><creatorcontrib>EGAN, AOIFE M.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MOAZZAMI, MITRA</au><au>VENKATESAN, NANDITHA</au><au>SANKARAN RAJAGOPALAN, KAMALNATH</au><au>VELLA, ADRIAN</au><au>EGAN, AOIFE M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1207-P: Gestational Diabetes Mellitus (GDM)—Outcomes for Normal-Weight Individuals</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2023-06-20</date><risdate>2023</risdate><volume>72</volume><issue>Supplement_1</issue><spage>1</spage><pages>1-</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract><![CDATA[Excess body weight is associated with GDM, and BMI ≥ 25kg/m2 is often used as a criterion in risk factor-based screening programs. However, individuals with a normal BMI account for a significant proportion of those diagnosed with GDM (20-60% depending on the population studied), and comparative clinical outcome data are limited. Our aim was to assess pregnancy outcomes for people with GDM and a baseline BMI < 25kg/m2, compared to a reference group with GDM and a BMI of 25-30kg/m2. Included subjects attended our institution for prenatal care from 2018-22 and GDM was diagnosed using universal screening and Carpenter and Coustan criteria. We identified 524 individuals with a BMI < 25kg/m2 and 705 with a BMI 25-30kg/m2. Those with a BMI <25 kg/m2 were younger (22 v 28 years, p<0.001), and a higher proportion identified as Asian (15.5% v 9.22%; p=0.04). Table 1 contains pregnancy outcomes. Those with a BMI <25kg/m2 were less likely to receive pharmacological GDM therapy, but their infants had a higher rate of neonatal ICU admission. Postpartum, those with a BMI <25kg/m2 were less likely to have an oral glucose tolerance test but were at similar risk of glucose intolerance. These findings suggest that normal weight women with GDM may experience higher risk of adverse outcomes compared to their overweight counterparts. These data support universal screening and will be used to inform patients on their risk profile and improve postpartum screening.]]></abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db23-1207-P</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0012-1797 |
| ispartof | Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1 |
| issn | 0012-1797 1939-327X |
| language | eng |
| recordid | cdi_proquest_journals_2849359685 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Body weight Diabetes mellitus Gestational diabetes Glucose tolerance Intolerance Neonates Overweight Population studies Postpartum Pregnancy complications Risk factors |
| title | 1207-P: Gestational Diabetes Mellitus (GDM)—Outcomes for Normal-Weight Individuals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T23%3A32%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1207-P:%20Gestational%20Diabetes%20Mellitus%20(GDM)%E2%80%94Outcomes%20for%20Normal-Weight%20Individuals&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=MOAZZAMI,%20MITRA&rft.date=2023-06-20&rft.volume=72&rft.issue=Supplement_1&rft.spage=1&rft.pages=1-&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db23-1207-P&rft_dat=%3Cproquest_cross%3E2849359685%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2849359685&rft_id=info:pmid/&rfr_iscdi=true |